Neurotransmitter Modulation (Sikiri et al., 1999) BPC-157 modulates dopamine D2 receptors, serotonin transporters, and related pathways in rat brains
Possible Side Effects Most side effects are mild and temporary: Gastrointestinal: nausea, vomiting, diarrhea, constipation, bloating, stomach discomfort Neurological: headache, dizziness Injection site reactions: redness, swelling, or mild pain Rare but serious: pancreatitis, gallbladder issues, thyroid changes, low blood sugar in diabetic patients Our team will guide you through dosing, administration, and monitoring to ensure your safety and comfort
Here is a realistic breakdown of the first year
40,105 However, given that IGF-1R and insulin receptor have decreased affinity for each others main ligand in comparison to their main ligand, it is likely that insulin and IGF-1 cannot stimulate the anabolic effects of each others receptor activation to the same degree as the main ligands for insulin receptor and IGF-1R at physiological concentrations